Ketek Linked To Liver Failure

The FDA is now warning of new dangers associated with Ketek, the first antibiotic of the ketolide class. Primarily used in treatment for chronic bronchitis, acute bacterial sinusitis and varying levels types of pneumonia, Ketek has been linked to rare cases of serious liver injury and liver failure. At least four confirmed deaths have been linked to the drug. To address these issues, the manufacturer, Sanofi Aventis, has now revised its warning label.